Skip to content
Skindermlab
EN
CaHA-Based Collagen Stimulator - Biostimulators product
Biostimulators

CaHA-Based Collagen Stimulator

The dual-action name in the biostimulator family: calcium hydroxyapatite (CaHA) microspheres deliver immediate volume while the gel carrier drives long-term collagen production.

CaHA stands apart from other biostimulators in the category through its dual mechanism of action: calcium hydroxyapatite microspheres provide immediate volume at the moment of injection, while the gel matrix carrying those microspheres is gradually resorbed and replaced by the body's own newly produced collagen. This biocompatible mineral, naturally present in bone, is one of the leading names in the 2026 biostimulator trend summed up as "regeneration over replacement" — favored in clinical protocols that want both an immediately visible result and lasting tissue support. Microsphere concentration and gel viscosity are set specifically to your brand; supplied in sterile, pre-filled syringe format, ready for production.

  • Immediate volume from microspheres, long-term collagen support from the gel matrix
  • A dual mechanism of action rare in the category
  • Suited to protocols wanting both immediate and lasting results
  • High biocompatibility as a mineral structure naturally found in bone
  • Custom microsphere concentration and viscosity options under your brand
  • Sterile, pre-filled syringe format

Want to manufacture under your own brand?

Manufactured to GMP standards, delivered with an MSDS. Certifications

Key Ingredients

Calcium Hydroxyapatite (CaHA) Microspheres

Deliver immediate volume at the moment of injection; their bone-mineral structure provides high biocompatibility.

Carboxymethylcellulose (CMC) Gel Matrix

The carrier gel suspending the microspheres; gradually resorbed and replaced by the body's own collagen over time.

How to Use

  1. 1Applied via deep dermal or subcutaneous injection technique to the target area using a sterile syringe.
  2. 2Following the immediate volume effect, gradual collagen production is observed over 2-6 months as the gel matrix resorbs.
  3. 3Clinical protocols may plan a single session or repeat sessions 4-6 weeks apart.
  4. 4Results are typically expected to last around 12-18 months, with maintenance sessions planned accordingly.

Frequently Asked Questions

What sets CaHA apart from your PLLA or PCL-based products?

CaHA has a dual mechanism of action: microspheres provide immediate volume while the gel matrix triggers collagen production. PLLA and PCL, by contrast, work entirely through gradual collagen stimulation without an immediate volume effect. You can offer these as two distinct segments — "immediate + gradual" versus "purely gradual."

How is microsphere concentration determined for my brand?

Microsphere density and gel viscosity can be adjusted based on the target area (face, hand, etc.) and your clinical protocol; we offer different concentration tiers.

What packaging format is the product delivered in?

We deliver it in sterile, pre-filled syringe format with custom labeling and box design under your brand.

How is quality and safety documentation handled?

Production takes place under GMP-standard sterile conditions; we deliver product registration, MSDS reports, and biocompatibility analysis certificates along with production.

Similar Products